Creating a Pediatric Hematology/Oncology Manuscript to Submit for Publication in a Nursing Journal (003)

3.25CNE  Increasing numbers of pediatric oncology nurses are completing advanced degrees, including the DNP and PhD. These nurses are advancing nursing discipline, science, evidence, and clinical practice by publishing their scholarly work. The experience of publishing in a professional nursing journal can be confusing and overwhelming to both novice and seasoned authors.
Read more...

Integrative Medicine in Pediatric and Adolescent Oncology: An Overview for the Nurse and Nurse Practitioner (008)

3.25CNE  The journey through cancer therapy is complex. While no two patients experience it the same way, there are predictable similarities when considering patient age, diagnosis, and therapy that is administered. Common problems encountered by many patients include diminished energy and physical stamina, neuropathy, disturbed sleep, poor appetite, weight loss, and exaggerated nausea.

Integrative medicine combines mainstream medical therapies with complementary therapies for which there is high quality scientific evidence of safety and effectiveness. In the setting of active treatment for children and adolescents with cancer, it consists primarily of complementary therapies intended to support general health or to limit specific treatment related toxicity. Numerous modalities may fall within this category, including dietary modification, nutrient and botanical supplements or applications, guided imagery, aromatherapy, acupuncture, and massage. It is estimated that 30–70% of pediatric patients use integrative medicine strategies; since this is by parental report, many studies likely underestimate their use.

Read more...

Changing the Game: New Updates and Innovative Approaches for Chemotherapy and Biotherapy Provider Course Instructors (007)

3.25CNE  The 4th edition of the APHON Chemotherapy and Biotherapy Curriculum contains a wealth of updated information for the nurse who administers chemotherapy and biotherapy. Changes include enhanced explanations of foundational concepts, expanded information about biotherapy and biotherapy agents, updated safe handling guidelines, additions to toxicities, additional tables and figures, useful algorithms, and much more. The editors and contributors of the 4th edition have conscientiously worked to incorporate all of these changes into a practical and useful nursing resource that is substantially different than its predecessors. Commensurate with the updates in the curriculum, come changes to the provider course—not only in content but also in teaching strategies. Current models of adult learning move away from traditional didactic lectures and instead focus on active learning and increased learner engagement in the education process (Curran, 2014; Hart, 2017). The provider course for the 4th edition repositions instructors as facilitators of learning and presents the curriculum content in an innovative, interactive approach. When the 4th edition curriculum is published, the previous curriculum and provider course will be retired. Currently, there are over 550 trained Chemotherapy and Biotherapy instructors who are leading provider courses. To prepare these seasoned instructors for the transition, the Chemotherapy and Biotherapy Committee is working diligently to ensure that every instructor has the opportunity to preview and experience the revised materials. This preconference workshop will provide current Chemotherapy and Biotherapy instructors an engaging introduction to the 4th edition of the Chemotherapy and Biotherapy Curriculum and Provider Course.

Interested attendees of this pre-conference workshop must be a current APHON Pediatric Chemotherapy and Biotherapy Instructor and a current APHON member. 

Read more...

Bone Marrow Transplant for Hematology Patients: Caring for the Patient from Diagnosis to Long Term Follow Up (006)

3.25CNE  There are an increasing numbers of patients with hematologic transplant as a curative therapy, for previously life-threatening and life-limiting diagnosis. There continues to be advancement in this area on options available to patients to allow for overall increased survival and improved outcomes. With these new advancements, there presents a challenge to manage these patients effectively pre- and post-transplant to improve outcomes and survival. This presentation will provide an overview of transplant for hematology patients, which will include indications for transplant, criteria to qualify for transplant, pre- and post-transplant considerations (infectious, social, etc.), an overview of medications specific to hematologic conditions prior to transplant; types of transplants used, hematologic specific complications pre- and post-transplant, long-term follow up considerations in the post-transplant patient, and new and emerging therapies in the hematology patient and transplant.

Read more...

The Self-Care Connection: Resiliency, Health, and Wellness (005)

3.25CNE  While the caring professions reap an abundance of benefits in the realms of compassion satisfaction and relationship building, they are also at risk for a multiplicity of professional pitfalls, such as moral distress, vicarious trauma, compassion fatigue, and burnout. Oftentimes individuals fail to make the connection between self-care and professional satisfaction. This workshop will discuss the importance of resiliency and self-care through lecture, hands-on activities and reflection.

Read more...

Consulting, Arranging and Referring: How to Create the Connections Needed for a Successful CAR T Patient Experience (004)

3.25CNE  Leukemia is the number one cause of pediatric cancer mortality. In addition, there are poor outcomes for second and greater relapses of ALL, so there is a need for new novel therapies (Novartis, 2015). Chimeric antigen receptor-engineered T cells (CAR T cells) have yielded unprecedented efficacy in B cell malignancies, most remarkably in anti-CD19 CAR T cells for B cell acute lymphoblastic leukemia (B-ALL) with up to a 90% complete remission rate. (Wang, Wu Han, 2017). Because CAR-T therapy success can be contingent on factors such as disease burden and previous therapy, communication between referring and referral centers to facilitate rapid consultation is essential.

Read more...
Subscribe to this RSS feed